Agilent Technologies

Ole Gron has been in the pharmaceutical industry for over 10 years after finding his way into separation science via spectroscopy.

Concluding our series on two-dimensional liquid chromatography, we talk with a pair of relative newcomers who relate their experiences to date and discuss how they plan to take advantage of the technique in the future.

Over 10 years ago, the potential of two-dimensional liquid chromatography seemed obvious to me – so I built a system and never looked back.

Impurity analysis with simultaneous determination of enantiomeric composition using the Agilent 1290 Infinity 2D-LC Solution

In recent years, the top ten pharmaceuticals sales list has been extensively populated with protein therapeutics, such as monoclonal antibodies and recombinant proteins, that are used to treat various life-threatening diseases, including cancer and autoimmune diseases.

Two-dimensional liquid chromatography certainly sounds impressive and produces some pretty pictures, but is it essential in the analysis of complex samples? Here, we show that 2D-LC offers both style and substance.

Agilent Technology’s Markets and Applications Programs – MAPs for short – connect you to a growing network of expertise to provide working solutions for your analytical business.

Comprehensive 2D-LC Analysis with Combination of Normal-Phase and Reversed-Phase

Dwight Stoll has been working in 2D-LC since 2000. Here, he talks about the benefits of what is a core technology in his research.

Moving from 1D to 2D liquid chromatography is a big step towards the high peak capacities demanded by complex sample analysis.